Related references
Note: Only part of the references are listed.Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets
Jun Gi Hwang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
2020 International Society of Hypertension global hypertension practice guidelines
Thomas Unger et al.
JOURNAL OF HYPERTENSION (2020)
Adherence in Hypertension A Review of Prevalence, Risk Factors, Impact, and Management
Michel Burnier et al.
CIRCULATION RESEARCH (2019)
Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study
John K. Lin et al.
LANCET GLOBAL HEALTH (2019)
Updates to Adherence to Hypertension Medications
Paola C. Roldan et al.
CURRENT HYPERTENSION REPORTS (2018)
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives
Fabio Angeli et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
Minkyung Oh et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Drug adherence in hypertension
M. Burnier
PHARMACOLOGICAL RESEARCH (2017)
Absolute bioavailability and pharmacokinetics of the angiotensin II receptor antagonist fimasartan in healthy subjects
Jong-Lyul Ghim et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy
Kwang-il Kim et al.
CLINICAL THERAPEUTICS (2016)
A Randomized, Double-blind, Candesartan-controlled, Parallel Group Comparison Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Patients with Mild to Moderate Essential Hypertension
Jang Hoon Lee et al.
CLINICAL THERAPEUTICS (2016)
Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb Study) An Open-Label Observational Study
Jeong Bae Park et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2013)
Efficacy and Tolerability of Fimasartan, a New Angiotensin Receptor Blocker, Compared With Losartan (50/100 mg): A 12-Week, Phase III, Multicenter, Prospective, Randomized, Double-Blind, Parallel-Group, Dose Escalation Clinical Trial With an Optional 12-Week Extension Phase in Adult Korean Patients With Mild-to-Moderate Hypertension
Sang Eun Lee et al.
CLINICAL THERAPEUTICS (2012)
Initial Monotherapy and Combination Therapy and Hypertension Control the First Year
Brent M. Egan et al.
HYPERTENSION (2012)
The effect of antihypertensive treatment on headache and blood pressure variability in randomized controlled trials: a systematic review
Alastair John Stewart Webb et al.
JOURNAL OF NEUROLOGY (2012)
Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA
Vangelis Karalis et al.
PHARMACEUTICAL RESEARCH (2012)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Fimasartan Following Single and Repeated Oral Administration in the Fasted and Fed States in Healthy Subjects
Yong Ha Chi et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2011)
Pharmacokinetic Interaction of Fimasartan, a New Angiotensin II Receptor Antagonist, With Amlodipine in Healthy Volunteers
SoJeong Yi et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Adherence and persistence with taking medication to control high blood pressure
Martha N. Hill et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension
Toshihiko Ishimitsu et al.
HYPERTENSION RESEARCH (2009)
Fixed-dose combinations improve medication compliance: A meta-analysis
Sripal Bangalore et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
